Skip to main content
. 2024 Feb 23;15:1310286. doi: 10.3389/fphar.2024.1310286

TABLE 2.

The signals of AEs of pirfenidone at the SOC level in the FEARS database.

SOC name Case number PT Percentage (%)
Gastrointestinal disorders 9,927 21 30.63
General disorders and administration site conditions 8,009 8 24.71
Respiratory, thoracic and mediastinal disorders 4,694 44 14.48
Metabolism and nutrition disorders 2,168 7 6.69
Skin and subcutaneous tissue disorders 1969 9 6.08
Investigations 1925 21 5.94
Cardiac disorders 1,343 6 4.14
Psychiatric disorders 759 5 2.34
Injury, poisoning and procedural complications 748 6 2.31
Nervous system disorders 406 4 1.25
Immune system disorders 228 2 0.70
Renal and urinary disorders 69 1 0.21
Vascular disorders 66 5 0.20
Surgical and medical procedures 66 5 0.20
Social circumstances 14 1 0.04
Musculoskeletal and connective tissue disorders 8 1 0.02
Reproductive system and breast disorders 6 2 0.02
Infections and infestations 3 1 0.01
Ear and labyrinth disorders 3 1 0.01

Abbreviations: AEs, adverse events; SOC, system organ class; FAERS, food and drug administration adverse event reporting system; PT, preferred term.